NASDAQ: CLMTCalumet Inc Stock
$18.98+1.32 (+7.47%)
Updated Oct 3, 2024
CLMT Price
$18.98
Fair Value Price
N/A
Market Cap
$1.63B
52 Week Low
$9.97
52 Week High
$21.19
P/E
-36.5x
P/B
-2.88x
P/S
0.3x
PEG
N/A
Dividend Yield
N/A
Revenue
$4.27B
Earnings
-$42.80M
Gross Margin
10%
Operating Margin
4.52%
Profit Margin
-1%
Debt to Equity
-5.28
Operating Cash Flow
$10M
Beta
0.99
Next Earnings
Nov 7, 2024
Ex-Dividend
N/A
Next Dividend
N/A
CLMT Overview
Calumet Specialty Products Partners, L.P. manufactures, formulates, and markets slate of specialty branded products to various consumer-facing and industrial markets in North America and internationally. Its Specialty Products and Solutions segment offers various solvents, waxes, customized lubricating oils, white oils, petrolatums, gels, esters, and other products. The company's Montana/Renewables segment focuses on processing renewable feedstocks into renewable hydrogen, renewable natural gas, renewable propane, renewable naphtha, renewable kerosene/aviation fuel, and renewable diesel. This segment also processes Canadian crude oil into conventional gasoline, diesel, jet fuel, and specialty grades of asphalt. Its Performance Brands segment blends, packages, and markets high performance products through Royal Purple, Bel-Ray, and TruFuel brands. Calumet GP, LLC serves as the general partner for Calumet Specialty Products Partners, L.P. The company was founded in 1916 and is headquartered in Indianapolis, Indiana.
Zen Score
–
Industry Average (30)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how CLMT scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
CLMT is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
CLMT is unprofitable, so we are unable to assess its PEG ratio
PEG Value Valuation
CLMT's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
There are 35 more CLMT due diligence checks available for Premium users.
Be the first to know about important CLMT news, forecast changes, insider trades & much more!
CLMT News
Valuation
CLMT price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-36.5x
Industry
7.72x
Market
26.22x
CLMT price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
-2.88x
Industry
1.86x
CLMT's financial health
Profit margin
Revenue
$1.1B
Net Income
-$39.1M
Profit Margin
-3.4%
CLMT's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
CLMT's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$2.7B
Liabilities
$3.0B
Debt to equity
-5.28
CLMT's short-term liabilities ($1.22B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
CLMT's long-term liabilities ($1.77B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
CLMT's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
CLMT's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$66.5M
Investing
-$15.0M
Financing
-$68.3M
CLMT's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
CLMT vs Oil and Gas Stocks
Calumet Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.